Odyssey Therapeutics Statistics
Total Valuation
ODTX has a market cap or net worth of $864.68 million. The enterprise value is $715.05 million.
| Market Cap | 864.68M |
| Enterprise Value | 715.05M |
Important Dates
The last earnings date was Wednesday, June 17, 2026, after market close.
| Earnings Date | Jun 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ODTX has 47.88 million shares outstanding. The number of shares has increased by 538.14% in one year.
| Current Share Class | 47.88M |
| Shares Outstanding | 47.88M |
| Shares Change (YoY) | +538.14% |
| Shares Change (QoQ) | +479.39% |
| Owned by Insiders (%) | 2.36% |
| Owned by Institutions (%) | 10.44% |
| Float | 25.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 817.27 |
| Forward PS | n/a |
| PB Ratio | 4.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 675.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.33, with a Debt / Equity ratio of 0.15.
| Current Ratio | 8.33 |
| Quick Ratio | 7.91 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6,023.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -72.79% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $10,580 |
| Profits Per Employee | -$1.48M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 53.72 |
| Average Volume (20 Days) | 369,629 |
Short Selling Information
The latest short interest is 1.34 million, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 514,441 |
| Short % of Shares Out | 2.81% |
| Short % of Float | 5.19% |
| Short Ratio (days to cover) | 4.20 |
Income Statement
In the last 12 months, ODTX had revenue of $1.06 million and -$148.47 million in losses. Loss per share was -$35.91.
| Revenue | 1.06M |
| Gross Profit | -120.12M |
| Operating Income | -150.58M |
| Pretax Income | -149.48M |
| Net Income | -148.47M |
| EBITDA | -145.80M |
| EBIT | -150.58M |
| Loss Per Share | -$35.91 |
Balance Sheet
The company has $175.75 million in cash and $26.13 million in debt, with a net cash position of $149.62 million or $3.13 per share.
| Cash & Cash Equivalents | 175.75M |
| Total Debt | 26.13M |
| Net Cash | 149.62M |
| Net Cash Per Share | $3.13 |
| Equity (Book Value) | 179.86M |
| Book Value Per Share | -211.05 |
| Working Capital | 162.89M |
Cash Flow
In the last 12 months, operating cash flow was -$131.88 million and capital expenditures -$453,000, giving a free cash flow of -$132.34 million.
| Operating Cash Flow | -131.88M |
| Capital Expenditures | -453,000 |
| Depreciation & Amortization | 4.78M |
| Net Borrowing | 11,000 |
| Free Cash Flow | -132.34M |
| FCF Per Share | -$2.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | -14,232.42% |
| Pretax Margin | -14,128.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ODTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -538.14% |
| Shareholder Yield | -538.14% |
| Earnings Yield | -17.17% |
| FCF Yield | -15.30% |
Analyst Forecast
The average price target for ODTX is $32.00, which is 76.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 76.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ODTX has an Altman Z-Score of -5.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.02 |
| Piotroski F-Score | 1 |